PharmaCyte Biotech Inc (PMCB)

[LuCo]

$68,700,000 in debt and we are only Pre clinical trials. Add another 14 million for next year's stock compensation alone, add operating costs to that. This will easily break 100 million in debt next year before any human will be tested on. No one is going to fund this with simple rat tests. They'll just keep taking money from shareholders, no big deal.

Just think if the employees at NVLX only comp'd themselves 1 million or even 500,000. No thanks they said, why do that when there's endless supply of shareholder money they can live lavishly with? We'll stick with $3,000,000